Thank you for the re-post of info about the HOLDRS.
Of course, the mother-lode of info are the SEC filings.
For example, for BBH, the appropriate SEC filing is the --MERRILL LYNCH PIERCE FENNER & SMITH INC filed this 424B3 on 01/21/2000. the Prospectus which details the composition of
the 20 issues at formation and as modified by splits etc.
This is supplemented as required by 8K filings by the transfer agent, Bank of New York, which also documents changes in composition, eg. splits, and other modifications.
From the 424B3 of 1/21/2000==
BIOTECH HOLDERs
1,000,000,000 Depositary Receipts
Biotech HOLDRs(TM) Trust
This prospectus supplement amends and supplements certain information
contained in the accompanying prospectus dated November 22, 1999 relating to
the sale of up to 1,000,000,000 depositary receipts by Biotech HOLDRs SM Trust.
The share amounts specified in the table on page 9 of the accompanying
prospectus shall be replaced with the following:
Primary
Share Trading
Name of Company Ticker Amounts Market
--------------- ------ ------- -------
Amgen Inc. AMGN 46 NASDAQ
Genentech, Inc. DNA 22 NYSE
Biogen, Inc. BGEN 13 NASDAQ
Immunex Corporation IMNX 14 NASDAQ
PE Corp-PE Biosystems Group PEB 9 NYSE
MedImmune, Inc. MEDI 5 NASDAQ
Chiron Corporation CHIR 16 NASDAQ
Genzyme Corporation GENZ 7 NASDAQ
Gilead Sciences, Inc. GILD 4 NASDAQ
Sepracor Inc. (1) SEPR 3 NASDAQ
IDEC Pharmaceuticals Corporation(2) IDPH 4 NASDAQ
QLT Photo Therapeutics Inc. QLTI 5 NASDAQ
Millennium Pharmaceuticals, Inc. MLNM 3 NASDAQ
BioChem Pharma Inc. BCHE 9 NASDAQ
Affymetrix, Inc. AFFX 2 NASDAQ
Human Genome Sciences, Inc.(3) HGSI 2 NASDAQ
ICOS Corporation ICOS 4 NASDAQ
Enzon, Inc. ENZN 3 NASDAQ
Celera Genomics CRA 2 NYSE
Alkermes, Inc. ALKS 2 NASDAQ
*********
from the 8K filed 3/3/2000--
Item 5. Other Events
Immunex Corporation has declared a three-for-one stock split on its
common stock, to be effected by means of a stock dividend to shareholders of
record on March 6, 2000. The shares of common stock will begin trading on a
split-adjusted basis on March 21, 2000. At such date, the share amount of
Immunex Corporation represented by a round-lot of 100 Biotech HOLDRs will be 42.
MedImmune, Inc. has declared a three-for-one stock split on its common
stock, to be effected by means of a stock dividend to shareholders of record on
May 18, 2000. The shares of common stock will begin trading on a split-adjusted
basis on June 5, 2000. At such date, the share amount of MedImmune, Inc.
represented by a round-lot of 100 Biotech HOLDRs will be 15.
Sepracor Inc. declared a two-for-one stock split on its common stock,
to be effected by means of a stock dividend to shareholders of record on
February 1, 2000. The shares of common stock began trading on a split-adjusted
basis on February 28, 2000. The share amount of Sepracor Inc. represented by a
round-lot of 100 Biotech HOLDRs is 6.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
(99) Biotech HOLDRsSM Trust Prospectus Supplement No. 2 dated March 2, 2000 to Prospectus dated November 22, 1999.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
Date: March 3, 2000 By: /s/ Stephen G. Bodurtha --------------------------- Name: Stephen G. Bodurtha Title: Attorney-in-Fact
EXHIBIT INDEX
Number and Description of Exhibit Sequential --------------------------------- Page Number -----------
(99) Biotech HOLDRsSM Trust Prospectus Pg. 5 Supplement No. 2 dated March 2, 2000 to Prospectus dated November 22, 1999.
4 |
